Cross‐presenting dendritic cells are required for control of Leishmania major infection
暂无分享,去创建一个
K. Murphy | F. Tacchini-Cottier | C. Ronet | N. Fasel | S. Schuster | Vanessa Mack | D. Ashok | C. Lavanchy | M. Rosa | H. Acha-Orbea | S. F. Marraco
[1] M. Olivier,et al. Leishmania evades host immunity by inhibiting antigen cross-presentation through direct cleavage of the SNARE VAMP8. , 2013, Cell host & microbe.
[2] K. Murphy,et al. Specificity through cooperation: BATF–IRF interactions control immune-regulatory networks , 2013, Nature Reviews Immunology.
[3] Werner Müller,et al. T Cell-Derived IL-10 Determines Leishmaniasis Disease Outcome and Is Suppressed by a Dendritic Cell Based Vaccine , 2013, PLoS pathogens.
[4] P. Scott,et al. IL-17 Mediates Immunopathology in the Absence of IL-10 Following Leishmania major Infection , 2013, PLoS pathogens.
[5] S. Nutt,et al. CD8α+ DCs can be induced in the absence of transcription factors Id2, Nfil3, and Batf3. , 2013, Blood.
[6] Michael S. Behnke,et al. Compensatory dendritic cell development mediated by BATF-IRF interactions , 2012, Nature.
[7] K. Murphy,et al. DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues. , 2012, Blood.
[8] F. Tacchini-Cottier,et al. Does T Helper Differentiation Correlate with Resistance or Susceptibility to Infection with L. major? Some Insights From the Murine Model , 2012, Front. Immun..
[9] A. Debrabant,et al. Efficient Capture of Infected Neutrophils by Dendritic Cells in the Skin Inhibits the Early Anti-Leishmania Response , 2012, PLoS pathogens.
[10] Mark J. Miller,et al. CD8α(+) dendritic cells are an obligate cellular entry point for productive infection by Listeria monocytogenes. , 2011, Immunity.
[11] Michelle M. Sandau,et al. CD8α(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. , 2011, Immunity.
[12] Clare L. Bennett,et al. Langerhans cells are negative regulators of the anti-Leishmania response , 2011, The Journal of experimental medicine.
[13] W. Heath,et al. The CD8+ dendritic cell subset , 2010, Immunological reviews.
[14] F. Tacchini-Cottier,et al. Neutrophil-Derived CCL3 Is Essential for the Rapid Recruitment of Dendritic Cells to the Site of Leishmania major Inoculation in Resistant Mice , 2010, PLoS pathogens.
[15] F. Ginhoux,et al. The origin and development of nonlymphoid tissue CD103+ DCs , 2009, The Journal of experimental medicine.
[16] A. Brooks,et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells , 2009, Nature Immunology.
[17] Y. Iwakura,et al. IL-17 Promotes Progression of Cutaneous Leishmaniasis in Susceptible Mice1 , 2009, The Journal of Immunology.
[18] M. Ritter,et al. CD205 (DEC-205): A recognition receptor for apoptotic and necrotic self , 2009, Molecular immunology.
[19] B. Malissen,et al. Priming of CD8+ and CD4+ T Cells in Experimental Leishmaniasis Is Initiated by Different Dendritic Cell Subtypes1 , 2009, The Journal of Immunology.
[20] E. Unanue,et al. Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity , 2008, Science.
[21] L. Ng,et al. Migratory Dermal Dendritic Cells Act as Rapid Sensors of Protozoan Parasites , 2008, PLoS pathogens.
[22] Li Wu,et al. Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset , 2008, Proceedings of the National Academy of Sciences.
[23] B. León,et al. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. , 2007, Immunity.
[24] Sylvie Bertholet,et al. Leishmania Antigens Are Presented to CD8+ T Cells by a Transporter Associated with Antigen Processing-Independent Pathway In Vitro and In Vivo , 2006, The Journal of Immunology.
[25] N. Glaichenhaus,et al. Lymph Node Resident Rather Than Skin-Derived Dendritic Cells Initiate Specific T Cell Responses after Leishmania major Infection , 2006, The Journal of Immunology.
[26] Y. Belkaid,et al. A Role for CD103 in the Retention of CD4+CD25+ Treg and Control of Leishmania major Infection1 , 2005, The Journal of Immunology.
[27] R. Spinelli,et al. Dendritic cells in Leishmania infection. , 2004, Microbes and infection.
[28] Mark C Udey,et al. Requirements for Th1-dependent immunity against infection with Leishmania major. , 2004, Microbes and infection.
[29] H. Körner,et al. CD8α‐ and Langerin‐negative dendritic cells, but not Langerhans cells, act as principal antigen‐presenting cells in leishmaniasis , 2004, European journal of immunology.
[30] P. Scott,et al. MHC Class II Expression Restricted to CD8α+ and CD11b+ Dendritic Cells Is Sufficient for Control of Leishmania major , 2004, The Journal of experimental medicine.
[31] T. Kamradt,et al. Two waves of antigen‐containing dendritic cells in vivo in experimental Leishmania major infection , 2004, European journal of immunology.
[32] W. Paul,et al. The Relative Contribution of IL-4 Receptor Signaling and IL-10 to Susceptibility to Leishmania major1 , 2003, The Journal of Immunology.
[33] Y. Belkaid,et al. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity , 2002, Nature.
[34] D. Sacks,et al. The immunology of susceptibility and resistance to Leishmania major in mice , 2002, Nature Reviews Immunology.
[35] Scott N. Mueller,et al. The CD8α+ Dendritic Cell Is Responsible for Inducing Peripheral Self-Tolerance to Tissue-associated Antigens , 2002, The Journal of experimental medicine.
[36] H. Hochrein,et al. Hierarchy of Susceptibility of Dendritic Cell Subsets to Infection by Leishmania major: Inverse Relationship to Interleukin-12 Production , 2002, Infection and Immunity.
[37] P. Scott,et al. The Role of IL-12 in Maintaining Resistance to Leishmania major1 , 2002, The Journal of Immunology.
[38] Y. Belkaid,et al. The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile Cure , 2001, The Journal of experimental medicine.
[39] Y. Liu,et al. Dendritic Cell Subsets and Lineages, and Their Functions in Innate and Adaptive Immunity , 2001, Cell.
[40] N. Glaichenhaus,et al. The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[41] P. Scott,et al. IL-12 Is Required to Maintain a Th1 Response During Leishmania major Infection1 , 2000, The Journal of Immunology.
[42] J. Blackwell,et al. IL-13 Is a Susceptibility Factor for Leishmania major Infection , 2000, The Journal of Immunology.
[43] F. Mattner,et al. Interleukin-12 is indispensable for protective immunity against Leishmania major , 1997, Infection and immunity.
[44] P. Scott,et al. The Role of IL‐12 in Regulation of T Helper Cell Subsets in Vivo , 1996, Annals of the New York Academy of Sciences.
[45] M. Röllinghoff,et al. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen‐specific T cells , 1993, European journal of immunology.
[46] R. Schaub,et al. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response , 1993, The Journal of experimental medicine.
[47] B. F. Hall,et al. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. , 1989, Journal of immunology.
[48] T. Boon,et al. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice , 1985, Parasite immunology.
[49] R. Locksley,et al. The regulation of immunity to Leishmania major. , 1995, Annual review of immunology.
[50] J. Louis,et al. T-cell responses and immunity to experimental infection with leishmania major. , 1989, Annual review of immunology.